-
1 Comment
Tianjin Ringpu Bio-Technology Co., Ltd is currently in a long term uptrend where the price is trading 20.1% above its 200 day moving average.
From a valuation standpoint, the stock is 45.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.3.
Tianjin Ringpu Bio-Technology Co., Ltd's total revenue rose by 24.4% to $539M since the same quarter in the previous year.
Its net income has increased by 193.6% to $146M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.4% to $87M since the same quarter in the previous year.
Based on the above factors, Tianjin Ringpu Bio-Technology Co., Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| ISIN | CNE100000TV1 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Target Price | 22.645 |
|---|---|
| Dividend Yield | 2.3% |
| Beta | 0.71 |
| PE Ratio | 26.48 |
| Market Cap | 8B |
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company offers anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry, waterfowl, livestock, ruminant, and companion animals. The company also provides disease diagnosis and testing services, consisting of animal disease diagnosis and testing, animal-derives food testing, and feed and pharmaceutical analysis testing; veterinary drug evaluation services comprising preclinical safety evaluation and clinical evaluation services for universities, research institutes, enterprises, and other entities; and socialized veterinary services, such as monitoring, testing, immunizing, quarantine, and investigating epidemiological surveys related to animal diseases to local governments. Tianjin Ringpu Bio-Technology Co.,Ltd. was founded in 1998 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300119.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
